ABSI Stock Analysis: Buy, Sell, or Hold?
ABSI - Absci Corporation Common Stock
$2.73
-0.05 (-1.80%)
▼
5d:
-6.83%
30d:
-0.36%
90d:
-23.53%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
ABSI is down 6.3% this week, but smart money is accumulating calls. Top strike: $4 2026-05-15 with 2,589 OI. Call ratio: 72% View Scanner →
Strength: 5.4/10
Get Alerted When ABSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABSI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABSI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABSI is currently trading at $2.73, which is considered fair relative to its 30-day fair value range of $2.51 to $2.91.
Technical Outlook: Technically, ABSI is in a downtrend. Immediate support is located at $2.40, while resistance sits at $3.20.
Market Sentiment: ABSI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.03 (+188.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABSI is in a downtrend. Immediate support is located at $2.40, while resistance sits at $3.20.
Market Sentiment: ABSI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.03 (+188.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.51 -
$2.91
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 188.8% below Wall St target ($8.03)
- CAUTION: Recommendation downgraded due to -6.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.51 -
$2.91
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.41
Resistance Level
$3.20
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.17
Wall Street Target
$8.03
(+188.8%)
Revenue Growth (YoY)
-2.3%
Share & Embed Analysis
Last updated: March 30, 2026 10:10 AM ET
Data refreshes hourly during market hours. Next update: 11:10 AM
Data refreshes hourly during market hours. Next update: 11:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABSI showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Andreas Busch
BUY
100000 shares
2026-03-12
Sean Mcclain
SELL
26761 shares
2026-02-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 62 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 54 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
|
EXEL
Exelixis Inc |
BUY
20 analysts |
$47 | 62 BUY |
